The UK’s health service is fighting to keep its head above water, yet with a record-breaking winter flu pandemic sweeping
Drug Science is pleased to welcome three new industry partners to its groundbreaking medical cannabis study, T21 (formerly Project TWENTY21).
GW Pharmaceuticals has released further details of its cannabis development pipeline. With Epidiolex approved in the US last year it
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
